BioNTech
Latest
Pfizer, BioNtech say flu-COVID shot generates strong immune response in trial
Oct 26 (Reuters) - Pfizer and German partner BioNTech said on Thursday that their vaccine to prevent flu and COVID-19 generated a strong immune response against strains of the viruses…
Pfizer, BioNTech propose EU pays half for each cancelled COVID dose – FT
April 30 (Reuters) - Pfizer Inc and BioNTech's new proposal to the European Union, amid a glut of COVID-19 shots, includes a…
China to allow German expats to use German COVID-19 vaccines
BEIJING, Dec 10 (Reuters) - The Chinese foreign ministry said China and Germany had reached an agreement on providing "German vaccines" to…
Pfizer/BioNTech Omicron booster shows strong response after a month
Nov 4 (Reuters) - U.S. drugmaker Pfizer Inc and its German partner BioNTech said on Friday their Omicron-tailored shot targeting the BA.4/5…
Pfizer, BioNTech start COVID-flu combination vaccine study
Nov 3 (Reuters) - U.S. drugmaker Pfizer Inc and its German partner BioNTech have started an early-stage study to evaluate a combination…
Pfizer says updated booster protects against circulating COVID variants
Oct 13 (Reuters) - Pfizer Inc and its German partner BioNTech said on Thursday that their Omicron-adapted COVID-19 vaccine booster generated a…
BioNTech to expand trial programme for more anti-Omicron vaccine options
FRANKFURT, March 30 (Reuters) - BioNTech expanded an ongoing clinical trial programme to develop new vaccines and patterns of administration for better…
BioNTech pledges African access to its future cancer drugs
Feb 16 (Reuters) - Germany's BioNTech , which is preparing to produce its COVID-19 vaccine or other disease-preventing shots in Africa, said…
BioNTech says developed method to detect high-risk variants
German COVID-19 vaccine maker BioNTech said it developed a method to quickly determine whether a new virus variant is a cause for…
BioNTech CEO says possible to adapt vaccine quickly for Omicron
FRANKFURT, Dec 3 (Reuters) - Germany's BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the Omicron…